Éteres

2-Methoxy-5-nitropyridine is an experimental model for the study of nucleophilic substitution reactions. It has been shown to catalyze a variety of nucleophilic substitutions, such as the reaction between dimethylformamide and methoxide. The uptake of 2-methoxy-5-nitropyridine in human cells has been studied using the mitochondrial cytochrome P450 (mt2) receptors, where it has been found that this compound binds to mt2 receptors with high affinity. The optical properties of 2-methoxy-5-nitropyridine have been determined by spectroscopic analysis and found to be similar to those of nitro compounds. Toxicity studies have also demonstrated that 2-methoxy-5-nitropyridine can cause liver damage at high doses, but there is no evidence that it causes cancer or causes reproductive toxicity.

<p>5-Methoxy-L-tryptophan is a nonsteroidal anti-inflammatory drug that acts by inhibiting the synthesis of prostaglandins. It has been shown to have a clinical relevance in the treatment of cancer and ischemia reperfusion injury. 5-Methoxy-L-tryptophan has also been shown to be effective in the treatment of inflammatory diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn disease. 5-Methoxy-L-tryptophan is a precursor for serotonin, which regulates many physiological functions including pain perception. Tryptophan has also been found to increase epithelial mesenchymal transition (EMT) and repair mechanisms in fibroblasts. X-ray crystal structures have revealed that 5-methoxy tryptophan binds at the active site of xanthine oxidase, which is an enzyme involved in purine metabolism.</p>